olivlawolivlaw

olivLaw · European equity research

MAPFRE, S.A. MAP.MC

Spain · BME Madrid · ISIN ES0124244E34 · Vertical: Listed companies from Spain

4.21EUR+0.48% · 1 dayClose 05 Nov 2026

MAPFRE is an insurance and services group operating across several countries, active in non-life and life insurance and funeral services, with results set out in its 2025 annual report. In January 2026 the company closed a bond issue of 1,000 million euros, and its ROE target for 2025-2026 was set between 11% and 12%.

At the close of 05 Nov 2026, MAPFRE, S.A. (MAP.MC) stock was 4.21 EUR (+0.48% on the day), with dividend yield 427.76%, beta 0.69, 52-week range 3.63–4.57 EUR.

Data as of · AI analysis dated · Source: ESEF annual reports and closing prices, computed by olivLaw.

Market cap
unavailable
P/E (TTM)
unavailable
E/P (TTM)
unavailable
Dividend yield
427.76%
DPS 12m 18.00
Beta (2y)
0.69
Volatility (1y) 23%
52-week range
3.634.57

Price history

Loading chart…

Technical reading

RSI (14)
47.8
neutral
Bollinger (20, 2)
3.99 – 4.52
in the lower half of the band · %B 0.41 · band width 12.5%
SMA 50 / 200
4.33 / 4.17
mixed trend
MACD (12, 26, 9)
-0.06 / -0.04
MACD below signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyEURO STOXX 50vs EURO STOXX 50Vertical median
1 month−1.9%−0.6%−1.2 pp—
3 months−5.9%−4.2%−1.8 pp—
6 months+0.6%+4.3%−3.7 pp—
Year to date−1.7%+7.5%−9.2 pp—
1 year+6.6%+9.9%−3.3 pp+4.9%
3 years+113.4%+49.8%+63.5 pp+30.5%
5 years+116.6%+42.8%+73.7 pp—
Max drawdown (1y)
−15.8%
19 Dec 2025 → 09 Mar 2026
Max drawdown (5y)
−23.7%
11 Feb 2022 → 26 Jul 2022
Compound annual growth (5y)
+16.7%
EURO STOXX 50 +7.4%

Price returns, dividends excluded.

Quarterly results

ESEF annual reports carry no quarters: the results are annual (below).

E/P over time

EPS unavailable in the issuer's structured filings (e.g. a partnership reports per unit, not per share).

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Fiscal years

Fiscal year202320242025
Revenueunavailableunavailableunavailable
Revenue YoYunavailableunavailableunavailable
Net income677.2 m967.5 m1.1 bn
Net income YoYunavailable+42.9%+17.1%
Diluted EPSunavailableunavailableunavailable
Diluted EPS YoYunavailableunavailableunavailable
net %unavailableunavailableunavailable
Free cash flowunavailable1.4 bn1.6 bn

Balance sheet & financial health

Fiscal year 2025 · 31 Dec 2025

Cash
1.9 bn EUR
Financial debt
unavailable EUR
Net debt
unavailable EUR
Equity
10.5 bn EUR
Total assets
58.5 bn EUR
Debt / equity
unavailable
Current ratio
unavailable
ROE
11.0%
ROA
2.0%
FCF margin
unavailable

Financial statements (source on every figure)

Revenue and net income (EUR)

Income statement · EUR

Interest expense
2023
776.5 m
2024
727.9 m
2025
732.2 m

esef· 20 Oct 2026verified

Pre-tax income
2023
1.6 bn
2024
2.1 bn
2025
2.5 bn

esef· 20 Oct 2026verified

Income tax
2023
381.1 m
2024
512.5 m
2025
727.5 m

esef· 20 Oct 2026verified

Net income
2023
677.2 m
2024
967.5 m
2025
1.1 bn

esef· 20 Oct 2026verified

Dividend per share
2023
15.00
2024
16.00
2025
18.00

esef· 20 Oct 2026verified

Balance sheet · EUR

Cash
2023
2.1 bn
2024
1.7 bn
2025
1.9 bn

esef· 20 Oct 2026verified

Property, plant & equipment, net
2023
1.2 bn
2024
1.2 bn
2025
1.2 bn

esef· 20 Oct 2026verified

Goodwill
2023
1.4 bn
2024
1.4 bn
2025
1.2 bn

esef· 20 Oct 2026verified

Intangibles (excl. goodwill)
2023
1.3 bn
2024
1.2 bn
2025
1.1 bn

esef· 20 Oct 2026verified

Total assets
2023
54.9 bn
2024
56.7 bn
2025
58.5 bn

esef· 20 Oct 2026verified

Equity
2023
9.7 bn
2024
10.0 bn
2025
10.5 bn

esef· 20 Oct 2026verified

Cash flow · EUR

Operating cash flow
2023
—
2024
1.5 bn
2025
1.6 bn

esef· 20 Oct 2026verified

Capex
2023
67.3 m
2024
60.1 m
2025
65.0 m

esef· 20 Oct 2026verified

Free cash flow
2023
—
2024
1.4 bn ≈
2025
1.6 bn ≈

esef· 20 Oct 2026derived

Investing cash flow
2023
-673.6 m
2024
-746.9 m
2025
-405.2 m

esef· 20 Oct 2026verified

Financing cash flow
2023
-1.3 bn
2024
-1.1 bn
2025
-934.0 m

esef· 20 Oct 2026verified

Dividends paid
2023
964.4 m
2024
1.1 bn
2025
1.2 bn

esef· 20 Oct 2026verified

Share repurchases
2023
0
2024
0
2025
40.4 m

esef· 20 Oct 2026verified

Computed indicators

Growth

Revenue growth (YoY)
unavailable
input data missing
Revenue CAGR 3Y
unavailable
input data missing
Revenue CAGR 5Y
unavailable
input data missing
EBIT growth (YoY)
unavailable
input data missing
Net income growth (YoY)
17.1%
computed by olivLawFY 2025
Net income CAGR 3Y
unavailable
input data missing
Net income CAGR 5Y
unavailable
input data missing
EPS growth (YoY)
unavailable
input data missing
EPS CAGR 3Y
unavailable
input data missing
EPS CAGR 5Y
unavailable
input data missing
FCF growth (YoY)
9.5%
computed by olivLawFY 2025

Profitability

Gross margin
unavailable
input data missing
EBITDA margin
unavailable
input data missing
EBIT margin
unavailable
input data missing
Net margin
unavailable
input data missing
FCF margin
unavailable
input data missing

Returns

ROE
12.4%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
ROA
2.0%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
ROIC
unavailable
input data missing
ROCE
unavailable
input data missing
Payout ratio (EPS)
unavailable
input data missing
Payout ratio (FCF)
75.1%
computed by olivLawFY 2025

Balance sheet

Net debt
unavailable
input data missing
Net debt / EBITDA
unavailable
input data missing
Debt / equity
unavailable
input data missing
Interest coverage
unavailable
input data missing

Liquidity

Current ratio
unavailable
input data missing
Quick ratio
unavailable
input data missing
Cash ratio
unavailable
input data missing

Cash

Operating cash flow
1.6 bn EUR
computed by olivLawFY 2025
Capital expenditure
65.0 m EUR
computed by olivLawFY 2025
Free cash flow
1.6 bn EUR
computed by olivLawFY 2025
FCF conversion
139.1%
computed by olivLawFY 2025
Cash conversion
unavailable
input data missing

Efficiency

Days sales outstanding
unavailable
input data missing
Days inventory outstanding
unavailable
input data missing
Days payables outstanding
unavailable
input data missing
Cash conversion cycle
unavailable
input data missing

Market and valuation

Market capitalisation
unavailable
input data missing
Enterprise value
unavailable
input data missing
Market cap / net income TTM
unavailable
input data missing
P/E (TTM)
unavailable
input data missing
Earnings yield
unavailable
input data missing
P/B
unavailable
input data missing
P/S
unavailable
input data missing
EV/EBITDA
unavailable
input data missing
EV/EBIT
unavailable
input data missing
EV/Sales
unavailable
input data missing
P/FCF
unavailable
input data missing
FCF yield
unavailable
input data missing
Dividend yield
427.8%
computed by olivLawFY 2025
Shareholder yield (distributions)
unavailable
input data missing

1 indicators that do not apply to the sector.

Valuation

olivLaw classification

Insufficient data
What is missing
  • indicators available: 2 of at least 6
  • score weight coverage: 10.4% of at least 60%

A scoring methodology on indicators and valuation, not investment advice.

Closing price

4.21 EUR

05 Nov 2026Source: olivLaw, closing series

Market cap: unavailable

Key indicators

Market capitalisation
unavailable
input data missing
P/E (TTM)
unavailable
input data missing
P/B
unavailable
input data missing
EV/EBITDA
unavailable
input data missing
ROE
12.4%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
Net margin
unavailable
input data missing
Revenue growth (YoY)
unavailable
input data missing
Dividend yield
427.8%
computed by olivLawFY 2025

Coverage and freshness

18/37 reporting lines present
Latest full fiscal year: 2025
Latest reported period: 31 Dec 2025
Latest balance sheet date: 31 Dec 2025
Source: esefpublished 20 Oct 2026
verified 57

Score by group

10% · Insufficient data

Estimated value range

Low
244.80
EUR per share
Mid
282.46
EUR per share
High
333.82
EUR per share
Price: 4.21 EUR
The price is below the range
Potential to the central value: 6,612.5% (value / price − 1)
Margin of safety: 98.5% (1 − price / value)
Agreement between methods: single method · 1 methods used · 1 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 244.80 – 333.82 EUR.

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (EUR per share)

— — Mid · ▏ Price

Valuation methods

  • DCF (discounted cash flow)unavailable · input data missing
  • Peers: EV/EBITDAunavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
  • Peers: P/Eunavailable · input data missing
  • Dividend discount (DDM)244.80 – 333.82 (Mid 282.46)

Assumptions (illustrative, editorial)

Risk-free rate
3.0%
Equity risk premium
5.5%
Beta (default)
1.00
Cost of equity
8.5%
Terminal growth
2.0%

Factor scorecard

Insufficient data

Minimum-evidence gate: indicators available: 2 of at least 6; score weight coverage: 10.4% of at least 60%

FactorValueScoreWeight used
ROIC · Qualityunavailableunavailable—
Net margin · Qualityunavailableunavailable—
FCF conversion · Quality139.1%100 (on a fixed band)60%
Revenue CAGR 3Y · Growthunavailableunavailable—
EPS CAGR 3Y · Growthunavailableunavailable—
Net debt / EBITDA · Balance sheetunavailableunavailable—
Interest coverage · Balance sheetunavailableunavailable—
Current ratio · Balance sheetunavailableunavailable—
P/E (TTM) · Valuationunavailableunavailable—
EV/EBITDA · Valuationunavailableunavailable—
FCF yield · Valuationunavailableunavailable—
Shareholder yield (distributions) · Returnsunavailableunavailable—
Payout ratio (FCF) · Returns75.1%64 (on a fixed band)40%

Factors without a value were dropped; the remaining weights were renormalised.

Score groups

  • Balance sheet· partialunavailable · 0/3 factors with a value
  • Growth· partialunavailable · 0/2 factors with a value
  • Quality· partial100/100 · 1/3 factors with a value
  • Returns· partial64/100 · 1/2 factors with a value
  • Valuation· partialunavailable · 0/3 factors with a value

A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

Memo

MAPFRE S.A. (MAP.MC). Latest full fiscal year: 2025; data up to 2025-12-31.

Figures computed from the financial statements: ROE 12.4%.

The estimated value range is 244.80–333.82 EUR per share (median of 1 methods, agreement: single method); assumptions are illustrative. Against the central value of 282.46 EUR, the price of 4.21 EUR leaves a potential of 6,612.5% (value / price − 1) and a margin of safety of 98.5% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

Insufficient data for a verdict (indicators available: 2 of at least 6; score weight coverage: 10.4% of at least 60%).

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

  • FCF conversion: 139.1%
  • The price is below the estimated value range

What contradicts it

No signal among the computed factors. That is not an absence of risk: factors without data were not assessed, and business risks (margins, inventory, demand) are in the source-based analysis.

Not assessed (insufficient data or a ratio without meaning): ROIC, Net margin, Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, Interest coverage, Current ratio, P/E (TTM), EV/EBITDA, FCF yield, Shareholder yield (distributions).

Versus the vertical median

Listed companies from Spain · same country · compared with 40 companies

Multiples and returns vs the median

P/E
—
vertical median 20.6x
EV/EBITDA
—
vertical median —
P/S
—
vertical median 0.9x
P/B
—
vertical median 2.4x
ROE
12.4%
vertical median 10.7%
above median (+16.1%)
Net margin
—
vertical median 5.5%
EBIT margin
—
vertical median 10.2%
Revenue YoY
—
vertical median 2.9%
Net debt/EBITDA
—
vertical median -0.2x
Dividend yield
427.8%
vertical median 3.0%
above median (+14,328.9%)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
ELE.MCEndesa SA46.9 bn21.426.4%10.5%+0.5%+43% / +134%
AENA.MCAena S.m.e. SA42.6 bn19.924.2%34.0%+8.9%+21% / +79%
AMS.MCAmadeus It Group Sociedad Anonima26.2 bn19.826.9%20.5%+6.1%−6% / −5%
ACS.MCAcs Actividades De Construccion Y Servicios, S.A.21.9 bn23.019.9%1.9%+19.7%+7% / +134%
ANA.MCAcciona SA11.7 bn14.516.9%4.0%+5.5%+24% / +66%
FCC.MCFomento De Construcciones Y Contratas S.A.5.0 bn30.35.3%1.7%+6.9%−8% / −14%
FDR.MCFluidra S.A.3.8 bn21.310.9%7.8%+4.1%−17% / +4%
DIA.MCDistribuidora Internacional De Alimentacion SA2.7 bn20.6165.6%2.2%−2.7%+51% / +380,733%
CMO.MCCementos Molins S.A.2.5 bn13.614.3%18.0%−3.1%+31% / unavailable
ENO.MCElecnor SA2.4 bn21.910.5%2.5%+15.1%−3% / +58%
ALM.MCAlmirall S.A.2.4 bn51.13.1%4.2%+12.4%−11% / +32%
FAE.MCFaes Farma SA1.5 bn19.310.8%13.0%+23.7%+3% / +57%
AEDAS.MCAedas Homes SA1.0 bn17.157.8%7.0%−24.8%+0% / +38%
EDR.MCEdreams Odigeo SA574.4 m11.521.0%7.8%−0.4%+40% / −24%
EAT.MCAmRest Holdings SE506.0 m31.44.3%0.6%+0.1%−34% / −61%
ADX.MCAudax Renovables S.A.468.5 m23.99.3%1.0%−5.4%−23% / −18%
ATRY.MCAtrys Health, S.A.200.4 m—-49.5%-71.1%+8.5%−3% / −29%
ENER.MCEcoener, S.A.175.6 m32.24.2%6.4%+3.6%−34% / −6%
ADZ.MCAdolfo Dominguez SA62.9 m38.39.0%1.2%+1.8%+39% / +40%
DESA.MCDesarrollos Especiales De Sistemas De Anclaje S.A.44.8 m9.2152.3%10.0%+2.2%+19% / unavailable
EZE.MCGrupo Ezentis SA29.0 m——-9.3%+147.2%−30% / −37%
CLEO.MCCompañia Levantina De Edificacion Y Obras Publicas SA17.3 m14.44.1%3.4%+13.4%unavailable / unavailable
AYC.MCAyco Grupo Inmobiliario, S.A.16.4 m—-33.8%—−100.0%unavailable / unavailable
EBRO.MCEbro Foods, S.A.3.0 m0.010.0%7.7%−4.0%−0% / +19%
A3M.MCAtresmedia Corporacion De Medios De Comunicacion, S.A.——7.9%6.9%−2.7%+13% / +60%

1- and 3-year price returns: for MAP.MC from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

The engine has no published run for this company yet.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Scenarios are not available. input data missing

AI analysis

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

In brief

MAPFRE is an insurance and services group operating across several countries, active in non-life and life insurance and funeral services, with results set out in its 2025 annual report. In January 2026 the company closed a bond issue of 1,000 million euros, and its ROE target for 2025-2026 was set between 11% and 12% 1.

SWOT

Strengths

  • Broad geographic diversification across Europe, the Americas and Latin America, which reduces dependence on a single market.
  • Investment portfolio dominated by high credit quality fixed income securities, which supports balance sheet stability.
  • Integrated structure across non-life, life and related services, which can generate multiple income streams.

Weaknesses

  • Exposure to exchange rate movements can affect consolidated net equity, as the negative conversion differences in 2025 show.
  • Some cash generating units have tighter margins, which could make a reassessment of their value necessary.
  • Dependence of life income on the level of managed assets exposes results to market volatility.

Opportunities

  • Growing nearshoring in Mexico could support insurance demand in that country.
  • The premium growth and ROE improvement targets could be met if non-life margins remain stable.
  • Access to capital markets financing, shown by the January 2026 issue, could support growth plans.

Threats

  • A global economic slowdown and high public debt could reduce demand for insurance products.
  • Geopolitical tensions and more restrictive international trade could affect financial markets and activity in some regions.
  • Budget pressure in Europe from military spending could influence the yields of bonds held in the portfolio.

Risks

  • Market and interest rate riskhigh

    Changes in market prices or interest rates could reduce the value of the investment portfolio and income from life insurance.

  • Currency riskmedium

    Fluctuations of currencies against the euro could affect assets, liabilities and net equity, mainly through conversion differences.

  • Credit riskmedium

    Deterioration in the quality of bond issuers or counterparty insolvency could reduce yields and the value of investments.

  • Goodwill impairment riskmedium

    If assumptions on discount rates or long-term growth change, the recoverable value of some units could fall below their carrying amount.

  • Consumer behaviour risklow

    Economic uncertainty could reduce demand for insurance products and new policy sales.

Investment thesis

What would need to be true (bull case)

  • If the group meets its ROE target for 2025-2026 and keeps premium growth, profitability could support better value creation for shareholders.
  • Geographic diversification and presence in markets with growth potential, such as Mexico and Brazil, could offset pressures in Europe.
  • Access to bond market financing, shown by the January 2026 issue, could support expansion plans.

What would break the thesis

  • If economic slowdown and high public debt reduce demand for insurance, premium growth could fall short of the target.
  • Financial market volatility could affect portfolio value and life insurance income linked to assets.
  • Currency exposure and negative conversion differences could reduce net equity attributable to shareholders if the euro appreciates.

What to watch

  • Pace of premium growth excluding life savingsQ1 2027
  • Non-life combined ratio against the 94%-95% range2026
  • Impairment test results for Mapfre USA and BB Mapfre Participaçõesnext 10-K

Products, market & competition

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

The business

According to the consolidated annual report for 2025, MAPFRE, S.A. and its subsidiaries carry out non-life insurance, life insurance, asset management and related services, including funeral services in Spain. The group manages its financial investment portfolio mainly through high credit quality fixed income securities 1. The strategy for 2024-2026 aims at profitability, premium growth and a controlled combined ratio in non-life 1.

The group has a geographically diversified structure, with significant subsidiaries in Brazil, the United States, Mexico, the Dominican Republic and Central America, as well as operations in Spain, Portugal, Germany and other European countries 1. Goodwill and portfolio acquisition costs are allocated to cash generating units by business line 1.

Life business is linked to the value of assets under management, so market developments directly influence income from this line 1. The group manages market, credit and currency risks through a prudent investment policy and by matching the currencies of assets and liabilities 1.

Segments

Non-life insurance

Non-life includes major units in the United States (Mapfre USA), Brazil (BB Mapfre Participações), Germany (Verti) and Spain (Bankinter Seguros Generales). Impairment tests show a recoverable value for Mapfre USA of 1,832.2 million euros in 2025, against a carrying amount of 1,448.5 million 1.

Life insurance and savings

Life is concentrated in Mapfre Vida, Bankinter Vida and projects in Mexico and Brazil. The recoverable value of Mapfre Vida was estimated at 2,478.0 million euros in 2025, calculated from the present value of future profits from the in-force portfolio and new business 1.

Funeral and other services

The group also runs funeral services in Spain through Funespaña, as well as holdings in services and entertainment, including Puy Du Fou España, consolidated under the equity method 1.

Market context

The 2025 report describes a moderate global economic slowdown in 2026, with world growth of around 3.0%, and the United States and the Eurozone growing at different rates 1. Insurance markets are sensitive to public debt levels, monetary policy and capital market volatility 1.

Interest rate developments differ between the US and the euro area, and this difference affects financing conditions and consumer behaviour toward insurance products 1. Demand for insurance products could fall if economic uncertainty intensifies 1.

Trends

  • Lower interest ratesmixed

    The gradual reduction in interest rates during 2024-2025 could reduce the yield on fixed income portfolios, while supporting asset values and lower financing costs 1.

  • Higher military spending in Europeheadwind

    Rising defence spending in Europe could put pressure on public budgets and sovereign debt, a factor that could affect the bond markets in which the group invests 1.

  • Growth in Latin Americatailwind

    Brazil and Mexico are expected to grow moderately in 2026, and nearshoring towards North America could support insurance demand in Mexico 1.

  • Non-bank financial risks and high debtheadwind

    High public debt levels and exposure to non-bank financial institutions could amplify market shocks, which could affect the value of managed assets 1.

Competitive position

The annual report does not provide a detailed analysis of competitors, so competitive positions cannot be fully assessed from the available sources. The source does mention markets where the group operates, such as the United States, Brazil and Spain, where it competes with other insurers 1.

The differentiation the group pursues rests on geographic diversification, its distribution network and the quality of its investment portfolio, factors that could matter for maintaining market share 1.

  • Allianz SE

    European competitor with similar insurance and asset operations, cited in the context of the European insurance market.

  • AXA SA

    European insurance group with international presence, relevant for comparison in non-life and life business.

  • Assicurazioni Generali

    European insurer active in Italy and other European markets, competing in life and non-life segments.

  • Progressive CorporationPGR

    US motor insurer, a relevant competitor for non-life activity in the United States.

News & filings

In the press

No news in our archive over the last 180 days.

Annual reports (ESEF)

Sources

  1. [1] Annual report, fiscal year ended 2025-12-31 (ESEF) · SEC / MAPFRE, S.A. · 31 Dec 2025

Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.

MAPFRE, S.A. (MAP.MC): stock, results, valuation and forecast · olivLaw